Beam Therapeutics Inc.
BEAM
$31.58
-$0.17-0.54%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -138.61% | 316.71% | -10.20% | 5.57% | -19.90% |
| Total Depreciation and Amortization | -1.11% | 1.94% | 0.40% | 0.18% | 1.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 106.82% | -805.19% | 94.59% | -30.86% | -16.75% |
| Change in Net Operating Assets | 45.40% | -1,329.81% | -307.09% | 113.51% | -22.74% |
| Cash from Operations | -54.30% | -2.22% | -6.58% | 26.41% | -36.04% |
| Capital Expenditure | 40.22% | 25.48% | -59.79% | -2.32% | -3.20% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -75.48% | 58.52% | 142.29% | -37.08% | -194.41% |
| Cash from Investing | -76.69% | 65.12% | 138.53% | -36.23% | -199.06% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 87.43% | 12.60% | 51.04% | -99.77% | 13,645.03% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5,022.38% | 12.60% | 51.04% | -99.77% | 13,645.03% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -124.57% | 290.85% | 94.24% | -200.55% | 358.04% |